Clinical Trials Logo

Unresectable Meningioma clinical trials

View clinical trials related to Unresectable Meningioma.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04082520 Recruiting - Clinical trials for Recurrent Meningioma

Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

Start date: April 8, 2020
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well lutathera works in treating patients with meningioma that cannot be treated with surgery (inoperable) and is growing, spreading, or getting worse (progressive) after external beam radiation therapy. Lutathera is a radioactive drug administered in the vein that is designed to target and kill tumor cells. The goal of this study is to determine whether this drug is safe and effective in treating meningiomas that progress after radiation treatment. WHO Grade I and Cohort WHO II/III cohorts will be evaluated.